When CRP was analysed as a continuous variable, the adjusted hazard ratios were 1.01(95%CI 1.00–1.03, p = 0.144, 1.02(95%CI 1.00–1.04, p = 0.057) and 1.00(95%CI 0.99–1.03, p = 0.860) for overall, cancer-specific and recurrence free survival respectively. This evidence concerns the gene CRP and cancer.